Chemoprevention of Colorectal Cancer
Top Cited Papers
- 29 June 2000
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (26) , 1960-1968
- https://doi.org/10.1056/nejm200006293422606
Abstract
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. It is estimated that this cancer will develop in 130,000 people in the United States in 2000 and that 56,000 will die from the disease.1 Surgical resection remains the only curative treatment, and the likelihood of cure is greater when the disease is detected at an earlier pathological stage. Early detection is the goal of screening programs that use periodic examination of stool for occult blood, with or without intermittent endoscopic examination of the bowel. Three randomized studies have shown a reduction in mortality of 15 . . .Keywords
This publication has 66 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)JNCI Journal of the National Cancer Institute, 1998
- Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosisProceedings of the National Academy of Sciences, 1998
- Participation in Colorectal Cancer Screening: A ReviewJNCI Journal of the National Cancer Institute, 1997
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Hereditary Gastrointestinal Polyposis and Nonpolyposis SyndromesNew England Journal of Medicine, 1994
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993
- Screening Sigmoidoscopy and Colorectal Cancer MortalityJNCI Journal of the National Cancer Institute, 1992
- Polyps and cancer of the large bowel: a necropsy study in Liverpool.Gut, 1982